Photo taken from Bojana Jovanovic/LinkedIn
Aug 26, 2024, 21:21
Integrative Multi-Omic Profiling of Triple Negative Breast Cancer – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X:
“This new study examines integrative multi-omic profiling of Triple Negative Breast Cancer for identifying suitable therapies. Rachel Freedman are leading efforts to improve access to clinical trials and to ensure that research reflects all communities.”
Integrative multi-omic profiling of triple-negative breast cancer for identifying suitable therapies
Authors: Bojana Jovanovic, Sarah E Church, Kara M Gorman, Khrystyna North, Edward T Richardson, Molly DiLullo, Victoria Attaya, Julie Kasparian, Ayesha Mohammed-Abreu, Gregory Kirkner, Melissa E Hughes, Nancy U Lin, Elizabeth A Mittendorf, Stuart J Schnitt, Sara M Tolaney, Shom Goel.
Ayesha Mohammed-Abreu
Bojana Jovanovic
Breast Oncology Center
cancer
Cancer research
clinical trials
Dana-Farber
Edward T Richardson
Elizabeth A. Mittendorf
Gregory Kirkner
integrative multi-omic profiling
Julie Kasparian
Kara M Gorman
Khrystyna North
Melissa E Hughes
Molly DiLullo
Nancy U Lin
OncoDaily
Oncology
Rachel Freedman
Sara M. Tolaney
Sarah E Church
Shom Goel
Stuart J Schnitt
TNBC
triple-negative breast cancer
Victoria Attaya
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 10:19
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29